Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry

被引：8

作者：

Castle, Philip E. ^{[1
,2
,3
]}

Kinney, Walter K.

Chen, Lu ^{[4
]}

Kim, Jane J. ^{[5
]}

Jenison, Steven ^{[6
]}

Rossi, Giovanna ^{[7
]}

Kang, Huining ^{[4
]}

Cuzick, Jack ^{[8
]}

Wheeler, Cosette M. ^{[9
]}

机构：

[1] Albert Einstein Coll Med, Bronx, NY 10467 USA

[2] NCI, Div Canc Prevent, NIH, Rockville, MD USA

[3] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA

[4] Univ New Mexico, Comprehens Canc Ctr, Biostat Shared Resource, Albuquerque, NM 87131 USA

[5] Harvard TH Chan, Sch Publ Hlth, Boston, MA USA

[6] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA

[7] Collect Act Strategies, Albuquerque, NM USA

[8] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England

[9] Univ New Mexico, Comprehens Canc Ctr, Ctr HPV Prevent, Albuquerque, NM 87131 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2022年 / 114卷 / 04期

基金：

美国国家卫生研究院;

关键词：

CANCER; INTERVALS; HPV; PREVENTION; BELIEFS;

D O I：

10.1093/jnci/djab173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In 2012, national recommendations for cervical cancer screening of women aged 30-64 years were quinquennial human papillomavirus and cytology cotesting or triennial cytology. Data from a statewide surveillance program in New Mexico demonstrated 65.2% (95% confidence interval [95% CI] = 64.6% to 65.7%) of women screened in 2019 had a negative cotest within the last 3 years. Percentages of women screened in 2013, 2016, and 2019 with a prior negative cotest more than 5 years and up to 7 years ago were 2.6% (95% CI = 2.2% to 2.9%), 2.1% (95% CI = 1.9% to 2.2%), and 6.5% (95% CI = 6.2% to 6.8%), respectively (2-sided P-trend < .001). Percentages of women screened in 2013, 2016, and 2019 with a prior negative cytology more than 5 years and up to 7 years ago were 3.8% (95% CI = 3.7% to 3.9%), 9.0% (95% CI = 8.7% to 9.3%), and 14.9% (95% CI = 14.4% to 15.4%), respectively (2-sided P-trend < .001). Thus, in 2019, only 12.7% (95% CI = 12.4% to 13.1%) of the 30 215 women aged 30-64 years underwent cotesting and 27.7% (95% CI = 27.1% to 28.3%) of the 18 733 underwent cytology at the recommended interval. The observed under- and overscreening could result in increases in cervical cancer incidence and harms and costs, respectively.

引用

页码：626 / 630

页数：5

共 14 条

[1] Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention [J].